XML 88 R79.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-based Compensation and Benefits - Summary of Restricted Stock Activity (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2021
Restricted Stock [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Unvested Restricted shares, Beginning (in shares) 165,137  
Unvested Restricted shares, Granted (in shares) 2,836  
Unvested Restricted shares, Vested (in shares) (633)  
Unvested Restricted shares, Forfeited (in shares) (1,162)  
Unvested Restricted shares, Ending (in shares) 166,178  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]    
Weighted average grant-date fair value, Beginning (in dollars per share) $ 38.28  
Weighted average grant-date fair value, Granted (in dollars per share) 40.49  
Weighted average grant-date fair value, Vested (in dollars per share) 36.22  
Weighted average grant-date fair value, Forfeited (in dollars per share) 38.69  
Weighted average grant-date fair value, Ending (in dollars per share) $ 38.33  
Performance stock units    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Unvested Restricted shares, Beginning (in shares) 155,857  
Unvested Restricted shares, Net adjustment due to performance (in shares) 12,084  
Unvested Restricted shares, Vested (in shares) (36,236)  
Unvested Restricted shares, Forfeited (in shares) (1,030)  
Unvested Restricted shares, Ending (in shares) 130,675  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]    
Weighted average grant-date fair value, Beginning (in dollars per share) $ 33.81  
Weighted average grant-date fair value, Net adjustment due to performance (in dollars per share) 24.58  
Weighted average grant-date fair value, Vested (in dollars per share) 24.58  
Weighted average grant-date fair value, Forfeited (in dollars per share) 37.67  
Weighted average grant-date fair value, Ending (in dollars per share) $ 35.49  
ROTA    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]    
Weighted average grant-date fair value, Granted (in dollars per share)   $ 40.83
TSR    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]    
Weighted average grant-date fair value, Granted (in dollars per share)   $ 35.25
Weighted average beginning measurement period price   $ 43.51